First-in-Human PfSPZ-LARC2 Vaccination/CHMI | MicrobiomeTrials← Back to trialsNCT06735209
First-in-Human PfSPZ-LARC2 Vaccination/CHMI
RecruitingPHASE1INTERVENTIONAL
Trial Details
Start: 2025-07-23Est. Completion: 2027-02-01
Enrollment target: 22 participants Locations- The University of Washington - Virology Research Clinic, Seattle, Washington, United States
Other microbiome trials you might be interested in
Malaria
Background:
Malaria is a disease that affects many people in Africa. It is caused by germs carried by some mosquitoes. …
Ou(SqrRoot)(Copyright)less(SqrRoot)(Copyright)bougou, MaliCompleted Nov 30, 2026
Dengue Fever
Background:
Some mosquitos carry viruses that can cause disease. Some examples are dengue and Zika. The mosquitos sprea…
Chbar Mon, Kampong Speu, CambodiaCompleted Jan 25, 2022